2[2]Schindler R.Causes and therapy of microinflammation in renal failure[J].Nephrol Dail Transplant,2004,19(5):34-40.
3[3]Tsirpanlis G,Bagos P,Loannou D,et al.The variability and accurate assessment of microinflammation in haemodialysis patients[J].Nephrol Dail Transplant,2004,19(1):150-157.
4[4]Rattazzi M,Puato M,Faggin G,et al.New markers of accelerated atherosclerosis in end-stage renal disease[J].Review J Nephrol,2003,16(1):11-20.
6[6]Tsirpanlis G,Chatzipanagiotou S,Nicolaou C,et al.Microinflammation versus inflammation in chronic renal failure patients[J].Kidney Int,2004,66(12):2093-2098.
二级参考文献9
1Reinhold M, Deppisch W, Hermann G. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int, 2001,59:271-279.
2Ikeda U, Ileda M, Seiono Y, et al. Interleukin -6 gene transcripts are expressed in atherrosclerotic lesion of the genetically hyperlipidemic rabbits. Atherosclerosis, 1992,92: 213-218.
3Antonio S, Elena M. Cardiac effects of chronic inflammation in dialysis patients. Nephrol Dial Transplant. 2002,17: 10-15.
4Kim K J, Yang WS, Kim SB, et al. Malnutrition, cardiac disease,and mortality: an integrated point of view. Am J Kindey Dis,1998, 32: 834-841.
5Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis,1998; 32: s112-s119.
6Ridker PM, Buring JE, Shin J. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparentl healthy women. Circulation, 1998,98:731-733.
7George A. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol,2001,12: 1549-1557.
8Vigushin DM, Pepys MB. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest, 1993,91: 1351-1357.
